2.56
price up icon8.94%   0.21
after-market Dopo l'orario di chiusura: 2.54 -0.02 -0.78%
loading
Precedente Chiudi:
$2.35
Aprire:
$2.4752
Volume 24 ore:
2.75M
Relative Volume:
0.49
Capitalizzazione di mercato:
$871.07M
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-7.3143
EPS:
-0.35
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
+14.80%
1M Prestazione:
+26.11%
6M Prestazione:
-7.58%
1 anno Prestazione:
-21.95%
Intervallo 1D:
Value
$2.47
$2.57
Intervallo di 1 settimana:
Value
$2.20
$2.57
Portata 52W:
Value
$1.54
$3.97

Nuvation Bio Inc Stock (NUVB) Company Profile

Name
Nome
Nuvation Bio Inc
Name
Telefono
(415) 754-3517
Name
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Name
Dipendente
273
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
NUVB's Discussions on Twitter

Confronta NUVB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NUVB
Nuvation Bio Inc
2.56 799.62M 0 -75.80M -68.07M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-23 Iniziato Citizens JMP Mkt Outperform
2024-03-27 Aggiornamento Jefferies Hold → Buy
2024-03-26 Aggiornamento BTIG Research Neutral → Buy
2023-01-06 Downgrade Jefferies Buy → Hold
2022-08-02 Downgrade BMO Capital Markets Outperform → Market Perform
2022-08-02 Downgrade BTIG Research Buy → Neutral
2022-05-04 Iniziato H.C. Wainwright Buy
2021-10-15 Ripresa BTIG Research Buy
2021-04-06 Iniziato RBC Capital Mkts Outperform
2021-03-08 Iniziato BMO Capital Markets Outperform
2021-03-08 Iniziato BTIG Research Buy
2021-03-08 Iniziato Cowen Outperform
2021-03-08 Iniziato Jefferies Buy
2021-03-08 Iniziato Wedbush Outperform
Mostra tutto

Nuvation Bio Inc Borsa (NUVB) Ultime notizie

pulisher
10:35 AM

What drives Nuvation Bio Inc. stock priceConsistent high-performance stocks - Autocar Professional

10:35 AM
pulisher
10:21 AM

Is Nuvation Bio Inc. a good long term investmentFree Consultation - Autocar Professional

10:21 AM
pulisher
08:51 AM

Nuvation Bio Inc. Stock Analysis and ForecastFree Stock Index Interpretation - Autocar Professional

08:51 AM
pulisher
02:12 AM

What analysts say about Nuvation Bio Inc. stockTremendous gains - jammulinksnews.com

02:12 AM
pulisher
Jul 18, 2025

Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Breakthrough for IDH1 Mutant Glioma - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Will Nuvation Bio Inc. stock benefit from interest rate changesLong Term Low Risk Growth - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Nuvation Bio Inc. stock a good hedge against inflationFree Investing Community - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Nuvation Bio Inc. stock attracts strong analyst attentionLow Risk Entry Points - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Nuvation Bio's Mysterious 5% Surge: A Deep Dive into the Unseen Drivers - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Nuvation Bio Inc. stock price move sharplyIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Nuvation Bio Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy - MSN

Jul 11, 2025
pulisher
Jul 10, 2025

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow

Jul 10, 2025
pulisher
Jul 09, 2025

Nuvation Bio's 16% Surge: A Deep Dive Into the Unseen Drivers - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Nuvation Bio's 11% Spike: A Deep Dive into the Unseen Drivers - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Nuvation Bio’s 7% Surge: A Technical and Market Flow Deep-Dive - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Nuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Jul 07, 2025
pulisher
Jul 07, 2025

Nuvation Bio’s SWOT analysis: IBTROZI approval boosts stock prospects By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 06, 2025

Nuvation Bio’s SWOT analysis: IBTROZI approval boosts stock prospects - Investing.com

Jul 06, 2025
pulisher
Jul 06, 2025

Positive week for Nuvation Bio Inc. (NYSE:NUVB) institutional investors who lost 31% over the past year - simplywall.st

Jul 06, 2025
pulisher
Jul 02, 2025

RBC Capital Lowers PT on Nuvation Bio (NUVB) to $6 But Keeps a Buy Rating - MSN

Jul 02, 2025
pulisher
Jun 30, 2025

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans - MSN

Jun 30, 2025
pulisher
Jun 30, 2025

Nuvation Bio Inc.(NYSE: NUVB) added to Russell 2500 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Nuvation Bio Inc.(NYSE: NUVB) added to Russell 2000 Growth Index - MarketScreener

Jun 29, 2025
pulisher
Jun 29, 2025

Digging for Diamonds in Biotech: Why Insider Buys Signal Opportunity in Nuvation Bio and Ardelyx - AInvest

Jun 29, 2025
pulisher
Jun 28, 2025

NUVB SEC FilingsNuvation Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 25, 2025

Nuvation Bio stock rating reiterated at Market Outperform by Citizens JMP - Investing.com South Africa

Jun 25, 2025
pulisher
Jun 24, 2025

Nuvation Bio's Taletrectinib Emerges as a Niche Oncology Leader with NCCN Endorsement - AInvest

Jun 24, 2025
pulisher
Jun 24, 2025

Nuvation Bio (NUVB) Gains NCCN Endorsement for Taletrectinib in - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Boston Herald - FinancialContent

Jun 24, 2025
pulisher
Jun 22, 2025

Nuvation Bio's Mysterious 10% Surge: A Technical & Market Flow Deep Dive - AInvest

Jun 22, 2025
pulisher
Jun 20, 2025

Nuvation Bio jumps after insiders purchase shares worth over $1.1M - MSN

Jun 20, 2025
pulisher
Jun 20, 2025

Nuvation Bio’s Mysterious 7% Surge: What’s Behind the Volatility? - AInvest

Jun 20, 2025
pulisher
Jun 19, 2025

Wealth Enhancement Advisory Services LLC Buys Shares of 10,140 Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Insider Buying: Stacy Markel Acquires 10,000 Shares of Nuvation Bio Inc (NUVB) - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Nuvation Bio: A Justified Fall Based On Post-Marketing Requirements (NYSE:NUVB) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 17, 2025

Nuvation Bio (NUVB): RBC Capital Maintains Rating, Lowers Price - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Nuvation Bio (NUVB): RBC Capital Maintains Rating, Lowers Price Target | NUVB Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Nuvation Bio (NUVB) Target Price Revised Amid Commercial Shift | NUVB Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Cuts Price Target on Nuvation Bio to $6 From $10, Keeps Outperform, Speculative Risk - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI™ (taletrectinib), Manufactured by Nuvation Bio Inc. - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Onco360 Has Been Selected as a National Specialty Pharmacy - GlobeNewswire

Jun 16, 2025
pulisher
Jun 14, 2025

Nuvation Bio’s SWOT analysis: FDA approval boosts stock prospects - Investing.com India

Jun 14, 2025
pulisher
Jun 13, 2025

Nuvation Bio’s SWOT analysis: FDA approval boosts stock prospects By Investing.com - Investing.com Nigeria

Jun 13, 2025

Nuvation Bio Inc Azioni (NUVB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):